Searched for
V SIMPSON EMMANUEL
Homegrown cell, gene therapy pioneer ImmunoACT turns profitable in first year of opsImmunoAct, an Indian cell and gene therapy company, has achieved profitability in its first full year, generating ₹62 crore in revenue and ...- Roche Pharma India to appoint Rajwinder Mehdwan as country general managerRoche Pharma India has announced that Rajwinder Mehdwan will take over as the country general manager from April 1, 2025, replacing V Simps...
- Roche launches top selling eye drug Vabysmo in IndiaRoche Pharma India launches Vabysmo, a medication for neovascular age-related macular degeneration and diabetic macular edema in India. The...
- Roche Pharma launches multiple sclerosis treatment drug in IndiaThe company has introduced Ocrevus (Ocrelizumab) which is the first and only approved disease modifying therapy for both Relapsing Remittin...
- Roche Pharma launches drug to treat breast cancerPHESGO was first approved by the US FDA in June 2020 during the peak of the Covid pandemic, by the European Medicines Agency (EMA) in Decem...
- Roche launches spinal muscular atrophy treatment drug in India priced at around Rs 6 lakh per bottleSince its launch, over 4,000 SMA patients across over 50 countries have benefitted from the drug, Roche said in a statement.
- Cipla to market Roche's Antibody Cocktail in IndiaCipla will distribute the product by leveraging its strong distribution strengths across the country, the companies said in a joint stateme...
- Roche India gets emergency use approval for antibody cocktail used in COVID-19 treatmentRoche said that the production process for this drug is “very complex” and the company will do everything to ensure an equitable distributi...
- Roche Pharma India expands partnership with Cipla for key oncology medicinesRoche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distrib...
- Roche looks to bring evidence-based medicine tech to IndiaLara Bezerra, Roche Managing Director (India), who moved from the troubled Venezuela market to India, told ET that as part of its long-term...
- Roche plans to step up India play, launches two new medicinesRoche said patients will be offered equated monthly instalment schemes for Perjeta and Kadcyla through financial institutions in the coming...
- Roche cuts Hepatitis C drug cost by 65% for government institutionsDrug major Roche has reduced the prices of its Hepatitis C treatment drug 'Exxura' by 65 per cent across all government institutions in Ind...
Load More
